Timing over Dose: Maternal Vitamin D, Periconceptional Window, and Early-Life Respiratory Programming

Area of Science:

• Obstetrics and Gynecology
• Pediatric Pulmonology
• Nutritional Immunology

Background:

• Vitamin D deficiency is common in pregnancy (40-60%) and linked to adverse outcomes.
• Childhood asthma is a major concern, and vitamin D plays a role in fetal lung and immune development.
• Previous trials showed a trend for reduced asthma with vitamin D but lacked statistical significance, possibly due to timing and population heterogeneity.

Purpose of the Study:

• To re-evaluate evidence on maternal vitamin D supplementation for offspring asthma prevention.
• To emphasize the critical developmental window for vitamin D's potential protective effects.
• To propose a shift in supplementation timing towards the periconceptional and first-trimester period.

Main Methods:

• Narrative synthesis of randomized trials, birth-cohort studies, and mechanistic investigations.
• Review of meta-analyses on maternal vitamin D, placental biology, and offspring asthma.
• Analysis of evidence through a developmental-timing lens.

Main Results:

• The periconceptional and first trimester are key for implantation, airway morphogenesis, and epigenetic programming.
• Current trials initiated vitamin D supplementation after crucial lung development stages were complete.
• Baseline vitamin D levels, VDBP, and 17q21 genotype act as effect modifiers, indicating personalized responses.

Conclusions:

• Supplementation before or during the first trimester, tailored to individual status, is a biologically plausible strategy.
• Existing trials did not test this optimal timing window.
• Future research should prioritize adequately powered preconceptional trials with detailed monitoring.